Showing results (211-220 of 240) with videos related to

Sort By:
Pageof 24
World Journal of Gastroenterology|September 26, 2022
Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogueAlnoor Ramji, Karen Doucette, Curtis Cooper, et al.
AIDS and Behavior|June 5, 2017
Lessons Learned From the Implementation of Seek, Test, Treat, Retain Interventions Using Mobile Phones and Text Messaging to Improve Engagement in HIV Care for Vulnerable Populations in the United StatesKaterina A Christopoulos, William E Cunningham, Curt G Beckwith, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 10, 2025
Dedicated Automatic Recall Hepatocellular Cancer Surveillance Programme Demonstrates High Retention: A Population-Based Cohort StudyMayur Brahmania, Stephen Congly, Yashasavi Sachar, et al.
CMAJ Open|June 10, 2017
Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort studyKeith C K Lau, Abdel Aziz Shaheen, Alexander A Aspinall, et al.
Gene Therapy|November 3, 1998
Pure populations of transduced primary human cells can be produced using GFP expressing herpes virus vectors and flow cytometryR S Coffin, S K Thomas, N S Thomas, et al.
Gastro Hep Advances|August 12, 2024
Severe Hepatic Steatosis Is Associated With Low-Level Viremia and Advanced Fibrosis in Patients With Chronic Hepatitis B in North AmericaHin Hin Ko, Nishi H Patel, Sarah Haylock-Jacobs, et al.
Journal for Immunotherapy of Cancer|August 8, 2020
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancerEva Crespo-Rodriguez, Katharina Bergerhoff, Galabina Bozhanova, et al.
Human Vaccines & Immunotherapeutics|August 3, 2019
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trialFabien Zoulim, Claire Fournier, François Habersetzer, et al.
Canadian Liver Journal|December 25, 2023
Real-world tertiary referral centre experience stopping nucleos(t)ide analogue therapy in patients with chronic hepatitis BHassan Azhari, Alexandra D Frolkis, Abdel Aziz Shaheen, et al.
Journal of Hepatology|January 8, 2016
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B)Henry L Y Chan, Sang Hoon Ahn, Ting-Tsung Chang, et al.
Pageof 24